Collaborative Care and Access Challenges in Managing R/R MM with GPRC5D Bispecific
Oncology Clinical Pharmacist Specialist Amir Ali delves into potential challenges related to access and the use of this therapy, providing a comprehensive perspective on the complexities of incorporating GPRC5-targeting bispecifics into R/R MM patient management.
EP: 1.Case Presentation: Clinical Decision Making in a R/R MM patient
EP: 2.Treatment Options in Late Line Relapsed/Refractory MM Patients
EP: 3.Role of GPRC5D in R/R MM Patients
EP: 4.Case Presentation: Clinical Decision Making in a Patient With R/R MM
EP: 5.Navigating Bispecific Administration: Protocols, Dosage, and Challenges in R/R MM
Now Viewing
EP: 6.Collaborative Care and Access Challenges in Managing R/R MM with GPRC5D Bispecific
EP: 7.Case Presentation: Clinical Decision Making for a Patient With R/R MM
EP: 8.Patient-Centric Care in R/R MM
EP: 9.Guiding Through Challenges: Insights for Caregivers of R/R MM Patients
EP: 10.APPs Focus on Education of Talquetamab Use and Administration in Multiple Myeloma
Related Videos
Related Content
Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
Ishmael Applewhite, BSN, RN-BC, OCN;Leslie Bennett, MSN, RN;Kathy Mooney, MSN, RN, ACNS-BC, BMTCN®, OCN®
May 6th 2024Podcast
Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
